YD Bio Limited (YDES)
Last updated: 2026-10-20 17:38:00. Prices reflect the latest regular market data. Stock price data is sourced from Massive.
Summary
YD Bio Limited (YDES) operates in the -- sector and is listed on NASDAQ. The stock is currently priced at $6.26, with a market capitalization of $419.39M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $1.70 to $22.00. This page covers its latest market performance, valuation, price trends and company information.
Key Market Data
$419.39M | |
$6.08 | |
$25.00 | |
$1.70 | |
$6.12 | |
22.76K | |
295.61K | |
-- | |
$22.00 | |
$1.70 | |
-- | |
-- |
YD Bio Limited (YDES) Stock Price Today
YD Bio Limited (YDES) is currently trading at $6.26 as of 2026-10-20 17:34:00, up 2.35% ($0.14) from the previous close of $6.12
During today's regular trading session, YDES has traded between $1.70 and $25.00, with a trading volume of 22.76K shares. The current price is near the lower end of today's range.
YD Bio Limited (YDES) 7-Day Stock Price Change
Over the past seven days, YD Bio Limited (YDES) moved from $6.73 to $6.26, representing a decline of 6.92% ($0.47).
The stock traded between $5.46 and $7.13 during the period. The latest price is near the middle of the 7-day range, indicating strong downward.
The average daily volume was 101.16 thousand shares, down versus the previous seven-day period, indicating lower trading activity.
YDES 52-Week Price Position
Position in Range: 22.5%
YDES is currently trading at $6.26, placing it 22.5% of the way from its 52-week low of $1.70 to its 52-week high of $22.00. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
What is YD Bio Limited (YDES)?
YD Bio Ltd is a biotechnology company focused on regulated diagnostics, life science clinical services and healthcare product commercialization. Its operations include DNA methylation-based oncology testing programs in the United States under an LDT framework with CLIA-certified and CAP-accredited laboratory partners. The Company also provides life science distribution and clinical trial supply chain services, including procurement, logistics coordination and compliance-focused support for clinical development programs. It maintains ocular health product commercialization operations in the United States and consumer healthcare distribution activities in Asia. The Company operates in the United States and Taiwan, with Taiwan generating maximum revenue.
YD Bio Limited Information
| Employees | 15 |
| Exchange | NASDAQ |
| Company Website |
How to Buy YD Bio Limited (YDES) Stock on MEXC
Eligible investors can buy real shares of YD Bio Limited (YDES) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.
Frequently Asked Questions (FAQ)
1.What is YD Bio Limited (YDES) stock price today?
2.Is YDES stock going up or down today?
3.What is YDES pre-market price?
4.What is YDES after-hours price?
5.Is YDES stock trading now?
6.Where does YDES sit relative to its 52-week high and low?
7.What sector is YD Bio Limited in?
8.What is YD Bio Limited's market capitalization and where is it listed?
9.How is YDES valued in terms of P/E ratio and EPS?
10.Does YD Bio Limited pay a dividend?
Explore More US Stocks
Search Stocks
YDES Stock Calculator
Estimate the value between YDES shares and USD.
YDES Shares to USD
1.00 YDES shares = 6.264 USD
Calculations are estimates based on the latest available price and are for reference only.


